JPWO2019238952A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019238952A5
JPWO2019238952A5 JP2021518998A JP2021518998A JPWO2019238952A5 JP WO2019238952 A5 JPWO2019238952 A5 JP WO2019238952A5 JP 2021518998 A JP2021518998 A JP 2021518998A JP 2021518998 A JP2021518998 A JP 2021518998A JP WO2019238952 A5 JPWO2019238952 A5 JP WO2019238952A5
Authority
JP
Japan
Prior art keywords
composition
composition according
stromal cells
formulated
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021518998A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021528489A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/065753 external-priority patent/WO2019238952A1/fr
Publication of JP2021528489A publication Critical patent/JP2021528489A/ja
Publication of JPWO2019238952A5 publication Critical patent/JPWO2019238952A5/ja
Pending legal-status Critical Current

Links

JP2021518998A 2018-06-15 2019-06-14 皮膚科用医薬組成物及びその使用 Pending JP2021528489A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18382430.9 2018-06-15
EP18382430 2018-06-15
PCT/EP2019/065753 WO2019238952A1 (fr) 2018-06-15 2019-06-14 Composition pharmaceutique pour dermatologie et ses utilisations

Publications (2)

Publication Number Publication Date
JP2021528489A JP2021528489A (ja) 2021-10-21
JPWO2019238952A5 true JPWO2019238952A5 (fr) 2022-06-22

Family

ID=62791699

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021518998A Pending JP2021528489A (ja) 2018-06-15 2019-06-14 皮膚科用医薬組成物及びその使用

Country Status (9)

Country Link
US (2) US11413314B2 (fr)
EP (2) EP3806872A1 (fr)
JP (1) JP2021528489A (fr)
KR (1) KR20210021358A (fr)
CN (1) CN112584846A (fr)
AU (1) AU2019287353A1 (fr)
CA (1) CA3103043A1 (fr)
MA (1) MA52883A (fr)
WO (1) WO2019238952A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL434622A1 (pl) * 2020-07-10 2022-01-17 Bioceltix Spółka Akcyjna Sposób enkapsulacji białkowej substancji czynnej wykorzystujący techniki elektroosadzania, immunomodulująca kompozycja zawierająca białkową substancję czynną oraz polimer oraz jej zastosowanie do wytwarzania kompozycji weterynaryjnej do leczenia atopowego zapalenia skóry u zwierząt
PL434621A1 (pl) * 2020-07-10 2022-01-17 Bioceltix Spółka Akcyjna Sposób enkapsulacji białkowej substancji czynnej wykorzystujący techniki elektroosadzania, immunomodulująca kompozycja zawierająca białkową substancję czynną oraz polimer oraz jej zastosowanie do wytwarzania kompozycji farmaceutycznej do leczenia atopowego zapalenia skóry u ludzi
JP7497094B1 (ja) 2023-09-07 2024-06-10 株式会社 バイオミメティクスシンパシーズ 腸内細菌叢改善のための組成物及びその応用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU729377B2 (en) 1997-10-23 2001-02-01 Asterias Biotherapeutics, Inc. Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture
US6139524A (en) 1998-10-16 2000-10-31 Scimed Life Systems, Inc. Stent delivery system with perfusion
US7122019B1 (en) 2000-11-28 2006-10-17 Flowmedica Inc. Intra-aortic renal drug delivery catheter
SG10201400793RA (en) 2005-09-23 2014-08-28 Cellerix Sl Cell populations having immunoregulatory activity, method for isolation and uses
EP2054506A1 (fr) * 2006-08-15 2009-05-06 Agency for Science, Technology and Research Milieu conditionné de cellules souches mésenchymateuses
CA2629652A1 (fr) 2007-04-24 2008-10-24 Yaojiong Wu Compositions permettant la prevention ou le traitement des defauts de la peau et methodes d'utilisation connexes
US20120052049A1 (en) * 2010-08-31 2012-03-01 Renovocyte, LLC Systemic, Allogenic Stem Cell Therapies For Treatment of Diseases in Animals
AU2012313352B2 (en) * 2011-09-23 2015-07-02 Cell Ideas Pty Ltd Stem cells and secretions for treatment of inflammatory conditions
WO2013082543A1 (fr) * 2011-11-30 2013-06-06 Advanced Cell Technology, Inc. Cellules stromales mésenchymateuses et utilisation s'y rapportant
WO2014203269A2 (fr) * 2013-06-17 2014-12-24 Kasiak Research Pvt. Ltd. Procédé d'isolement, de purification et d'expansion à l'échelle industrielle de cellules souches mésenchymateuses dérivées de tissu adipeux canin
KR101646236B1 (ko) * 2014-03-07 2016-08-08 (주)세포바이오 중간엽 줄기세포 유래 단백질을 함유하는 면역 반응 억제용 조성물
AU2015367275B2 (en) * 2014-12-19 2021-11-18 Cell Ideas Pty Ltd Improved cell therapies
CA3035931A1 (fr) 2015-09-08 2017-03-16 Cell Ideas Pty Ltd Procedes d'expansion de cellules et compositions therapeutiques
WO2017144552A1 (fr) 2016-02-22 2017-08-31 Centauri Biotech. S.L. Compositions cellulaires pharmaceutiques ou vétérinaires comprenant des cellules stromales mésenchymateuses (csm) et du diméthylsulfoxyde (dmso)
RU2646793C1 (ru) * 2016-12-13 2018-03-07 Акаев Ислам Умарович Средство для собак, обладающее регенеративной активностью

Similar Documents

Publication Publication Date Title
CN111918662B (zh) 包含来源于诱导性多能干细胞的间充质肝细胞及来源于其的外泌体的用于改善、预防或治疗皮肤疾病的组合物
CN111601881B (zh) 包含利用干扰素γ预处理的诱导多能干细胞来源的间充质干细胞及来源于其的外泌体的用于改善、预防或治疗皮肤疾病的组合物
KR101078419B1 (ko) 양수 내 태아 유래 중간엽줄기세포를 이용한 피부 상태개선용 조성물
Badowski et al. Mixed effects of long-term frozen storage on cord tissue stem cells
US9545370B2 (en) Bioactive compositions and methods for their preparation and use
TW200902718A (en) Procurement, isolation, and cryopreservation of endometrial/menstrual cells
US20220202875A1 (en) Methods And Compositions For Aesthetic And Cosmetic Treatment And Stimulating Hair Growth
JPH10511704A (ja) 少なくとも1つのクチビルバナ科植物の抽出物の組成物中の使用
US20230381227A1 (en) Mitochondrial compositions and methods for the treatment of skin and hair
JP7092886B2 (ja) 鳥類の卵から分離した細胞である胚盤葉多能性幹細胞、神経幹細胞、胚性線維芽細胞条件培地を有効成分とする細胞の増殖、肌の再生、及びシワ改善用の培地組成物
JP6185913B2 (ja) ヒトの皮膚真皮由来成体幹細胞
JP2023060299A (ja) 敗血症の治療のための、ワルトンジェリーから取得された間葉系幹細胞
KR101218101B1 (ko) 양수 내 태아 유래 중간엽줄기세포를 이용한 발모촉진용 조성물
JPWO2019238952A5 (fr)
CN112584846A (zh) 用于皮肤病的药物组合物及其用途
JP7072292B2 (ja) 抗炎症成分を分泌する幹細胞の培養方法およびその幹細胞培養液を含む抗炎症組成物
EP4257674A1 (fr) Procédé d'isolement et de culture de cellules souches de sang de cordon exprimant gdf-3 à un niveau élevé, et utilisation de gdf -3
CN107075474B (zh) 干细胞的未分化状态维持剂和增殖促进剂
JP6468895B2 (ja) 幹細胞の未分化状態維持剤及び増殖促進剤
WO2021224920A1 (fr) Procédés et compositions pour l'enrichissement de cellules cibles
Malakar et al. Stem cells: a potential regenerative medicine for treatment of diseases
WO2020036418A1 (fr) Procédé d'amélioration de fonction et de production en grande quantité de cellules de follicules pileux dans un milieu conditionné de cellules dérivées du placenta
CN113209135B (zh) 一种用于延缓皮肤衰老的间充质干细胞外泌体制剂
JP2015020997A (ja) 幹細胞由来成長因子産生促進剤
JP6529791B2 (ja) 幹細胞の未分化状態維持剤及び増殖促進剤